News from the FDA/CDC
Mircera is now indicated for dialysis-related anemia in patients aged 5-17 years with chronic kidney disease.
PITTSBURGH – Patients with SCD started on hydroxyurea before age 1 year had better lab and clinical results than did those started a few months...
Daily News Podcast
And there’s a new FDA approval for multiple myeloma.
From the Journals
Children with SCD still were doing better than those without the disease in up-to-date vaccination status.
SAN DIEGO – Ask parents if they’ve had a cavity in the last year.
The decision expands the drug’s indication to include first- and second-line use in children.
SALT LAKE CITY – Non-ionizing imaging technique could reveal early lung ventilation deficits in children undergoing hematopoietic stem cell...
SAN DIEGO – Bleeding episodes and need for treatment were more frequent among boys with types 1 and 2 von Willebrand disease.
The U.S. hemophilia drug market, which serves about 20,000 patients, is worth $4.6 billion a year.
“There aren’t a lot of options available to Medicaid programs in terms of controlling costs, because we don’t set the initial costs”